Close

AnPac Bio Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021, Increasing Approximately 130% Compared to Q1, 2020

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. HCP
6. BSX
7. SPY
8. PI
9. CNMD
10. NOW


Go back to AnPac Bio Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021, Increasing Approximately 130% Compared to Q1, 2020
(NASDAQ: ANPC) Delayed: 4.37 --0 (-0%)
Previous Close $4.37    52 Week High $ 
Open $4.37    52 Week Low $ 
Day High $4.37    P/E N/A 
Day Low $4.37    EPS $ 
Volume 73,040